Granulocyte Colony-Stimulating Factor Treatment Before Radiotherapy Protects Against Radiation-Induced Liver Disease in Mice

Radiation-induced liver disease (RILD) remains a major problem resulting from radiotherapy. In this scenario, immunotherapy with granulocyte colony-stimulating factor (G-CSF) arises as an attractive approach that might improve the injured liver. Here, we investigated G-CSF administration’s impact be...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Isalira Peroba Rezende Ramos, Marlon Lemos Dias, Alan Cesar Nunes De Moraes, Fernanda Guimarães Meireles Ferreira, Sergio Augusto Lopes Souza, Bianca Gutfilen, Thiago Barboza, Cibele Ferreira Pimentel, Cintia Marina Paz Batista, Tais Hanae Kasai-Brunswick, Fabio Da Silva De Azevedo Fortes, Cherley Borba Vieira De Andrade, Regina Coeli dos Santos Goldenberg
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/32e1ea3ca2f948629459a18832b3974e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:32e1ea3ca2f948629459a18832b3974e
record_format dspace
spelling oai:doaj.org-article:32e1ea3ca2f948629459a18832b3974e2021-11-15T06:57:17ZGranulocyte Colony-Stimulating Factor Treatment Before Radiotherapy Protects Against Radiation-Induced Liver Disease in Mice1663-981210.3389/fphar.2021.725084https://doaj.org/article/32e1ea3ca2f948629459a18832b3974e2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.725084/fullhttps://doaj.org/toc/1663-9812Radiation-induced liver disease (RILD) remains a major problem resulting from radiotherapy. In this scenario, immunotherapy with granulocyte colony-stimulating factor (G-CSF) arises as an attractive approach that might improve the injured liver. Here, we investigated G-CSF administration’s impact before and after liver irradiation exposure using an association of alcohol consumption and local irradiation to induce liver disease model in C57BL/6 mice. Male and female mice were submitted to a previous alcohol-induced liver injury protocol with water containing 5% alcohol for 90 days. Then, the animals were treated with G-CSF (100 μg/kg/d) for 3 days before or after liver irradiation (18 Gy). At days 7, 30, and 60 post-radiation, non-invasive liver images were acquired by ultrasonography, magnetic resonance, and computed tomography. Biochemical and histological evaluations were performed to verify whether G-CSF could prevent liver tissue damage or reverse the acute liver injury. Our data showed that the treatment with G-CSF before irradiation effectively improved morphofunctional parameters caused by RILD, restoring histological arrangement, promoting liver regeneration, preserving normal organelles distribution, and glycogen granules. The amount of OV-6 and F4/80-positive cells increased, and α-SMA positive cells’ presence was normalized. Additionally, prior G-CSF administration preserved serum biochemical parameters and increased the survival rates (100%). On the other hand, after irradiation, the treatment showed a slight improvement in survival rates (79%) and did not ameliorate RILD. Overall, our data suggest that G-CSF administration before radiation might be an immunotherapeutic alternative to radiotherapy planning to avoid RILD.Isalira Peroba Rezende RamosMarlon Lemos DiasMarlon Lemos DiasAlan Cesar Nunes De MoraesFernanda Guimarães Meireles FerreiraSergio Augusto Lopes SouzaBianca GutfilenThiago BarbozaCibele Ferreira PimentelCibele Ferreira PimentelCibele Ferreira PimentelCibele Ferreira PimentelCintia Marina Paz BatistaTais Hanae Kasai-BrunswickTais Hanae Kasai-BrunswickTais Hanae Kasai-BrunswickFabio Da Silva De Azevedo FortesFabio Da Silva De Azevedo FortesCherley Borba Vieira De AndradeCherley Borba Vieira De AndradeRegina Coeli dos Santos GoldenbergRegina Coeli dos Santos GoldenbergFrontiers Media S.A.articleliverirradiationimmunotherapyG-CSFalcoholultrasonographyTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic liver
irradiation
immunotherapy
G-CSF
alcohol
ultrasonography
Therapeutics. Pharmacology
RM1-950
spellingShingle liver
irradiation
immunotherapy
G-CSF
alcohol
ultrasonography
Therapeutics. Pharmacology
RM1-950
Isalira Peroba Rezende Ramos
Marlon Lemos Dias
Marlon Lemos Dias
Alan Cesar Nunes De Moraes
Fernanda Guimarães Meireles Ferreira
Sergio Augusto Lopes Souza
Bianca Gutfilen
Thiago Barboza
Cibele Ferreira Pimentel
Cibele Ferreira Pimentel
Cibele Ferreira Pimentel
Cibele Ferreira Pimentel
Cintia Marina Paz Batista
Tais Hanae Kasai-Brunswick
Tais Hanae Kasai-Brunswick
Tais Hanae Kasai-Brunswick
Fabio Da Silva De Azevedo Fortes
Fabio Da Silva De Azevedo Fortes
Cherley Borba Vieira De Andrade
Cherley Borba Vieira De Andrade
Regina Coeli dos Santos Goldenberg
Regina Coeli dos Santos Goldenberg
Granulocyte Colony-Stimulating Factor Treatment Before Radiotherapy Protects Against Radiation-Induced Liver Disease in Mice
description Radiation-induced liver disease (RILD) remains a major problem resulting from radiotherapy. In this scenario, immunotherapy with granulocyte colony-stimulating factor (G-CSF) arises as an attractive approach that might improve the injured liver. Here, we investigated G-CSF administration’s impact before and after liver irradiation exposure using an association of alcohol consumption and local irradiation to induce liver disease model in C57BL/6 mice. Male and female mice were submitted to a previous alcohol-induced liver injury protocol with water containing 5% alcohol for 90 days. Then, the animals were treated with G-CSF (100 μg/kg/d) for 3 days before or after liver irradiation (18 Gy). At days 7, 30, and 60 post-radiation, non-invasive liver images were acquired by ultrasonography, magnetic resonance, and computed tomography. Biochemical and histological evaluations were performed to verify whether G-CSF could prevent liver tissue damage or reverse the acute liver injury. Our data showed that the treatment with G-CSF before irradiation effectively improved morphofunctional parameters caused by RILD, restoring histological arrangement, promoting liver regeneration, preserving normal organelles distribution, and glycogen granules. The amount of OV-6 and F4/80-positive cells increased, and α-SMA positive cells’ presence was normalized. Additionally, prior G-CSF administration preserved serum biochemical parameters and increased the survival rates (100%). On the other hand, after irradiation, the treatment showed a slight improvement in survival rates (79%) and did not ameliorate RILD. Overall, our data suggest that G-CSF administration before radiation might be an immunotherapeutic alternative to radiotherapy planning to avoid RILD.
format article
author Isalira Peroba Rezende Ramos
Marlon Lemos Dias
Marlon Lemos Dias
Alan Cesar Nunes De Moraes
Fernanda Guimarães Meireles Ferreira
Sergio Augusto Lopes Souza
Bianca Gutfilen
Thiago Barboza
Cibele Ferreira Pimentel
Cibele Ferreira Pimentel
Cibele Ferreira Pimentel
Cibele Ferreira Pimentel
Cintia Marina Paz Batista
Tais Hanae Kasai-Brunswick
Tais Hanae Kasai-Brunswick
Tais Hanae Kasai-Brunswick
Fabio Da Silva De Azevedo Fortes
Fabio Da Silva De Azevedo Fortes
Cherley Borba Vieira De Andrade
Cherley Borba Vieira De Andrade
Regina Coeli dos Santos Goldenberg
Regina Coeli dos Santos Goldenberg
author_facet Isalira Peroba Rezende Ramos
Marlon Lemos Dias
Marlon Lemos Dias
Alan Cesar Nunes De Moraes
Fernanda Guimarães Meireles Ferreira
Sergio Augusto Lopes Souza
Bianca Gutfilen
Thiago Barboza
Cibele Ferreira Pimentel
Cibele Ferreira Pimentel
Cibele Ferreira Pimentel
Cibele Ferreira Pimentel
Cintia Marina Paz Batista
Tais Hanae Kasai-Brunswick
Tais Hanae Kasai-Brunswick
Tais Hanae Kasai-Brunswick
Fabio Da Silva De Azevedo Fortes
Fabio Da Silva De Azevedo Fortes
Cherley Borba Vieira De Andrade
Cherley Borba Vieira De Andrade
Regina Coeli dos Santos Goldenberg
Regina Coeli dos Santos Goldenberg
author_sort Isalira Peroba Rezende Ramos
title Granulocyte Colony-Stimulating Factor Treatment Before Radiotherapy Protects Against Radiation-Induced Liver Disease in Mice
title_short Granulocyte Colony-Stimulating Factor Treatment Before Radiotherapy Protects Against Radiation-Induced Liver Disease in Mice
title_full Granulocyte Colony-Stimulating Factor Treatment Before Radiotherapy Protects Against Radiation-Induced Liver Disease in Mice
title_fullStr Granulocyte Colony-Stimulating Factor Treatment Before Radiotherapy Protects Against Radiation-Induced Liver Disease in Mice
title_full_unstemmed Granulocyte Colony-Stimulating Factor Treatment Before Radiotherapy Protects Against Radiation-Induced Liver Disease in Mice
title_sort granulocyte colony-stimulating factor treatment before radiotherapy protects against radiation-induced liver disease in mice
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/32e1ea3ca2f948629459a18832b3974e
work_keys_str_mv AT isaliraperobarezenderamos granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT marlonlemosdias granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT marlonlemosdias granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT alancesarnunesdemoraes granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT fernandaguimaraesmeirelesferreira granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT sergioaugustolopessouza granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT biancagutfilen granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT thiagobarboza granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT cibeleferreirapimentel granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT cibeleferreirapimentel granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT cibeleferreirapimentel granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT cibeleferreirapimentel granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT cintiamarinapazbatista granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT taishanaekasaibrunswick granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT taishanaekasaibrunswick granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT taishanaekasaibrunswick granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT fabiodasilvadeazevedofortes granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT fabiodasilvadeazevedofortes granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT cherleyborbavieiradeandrade granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT cherleyborbavieiradeandrade granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT reginacoelidossantosgoldenberg granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
AT reginacoelidossantosgoldenberg granulocytecolonystimulatingfactortreatmentbeforeradiotherapyprotectsagainstradiationinducedliverdiseaseinmice
_version_ 1718428487190052864